Mit Holding Inc. (MITD) 0.0950 $MITD
MIT Holding, Inc. (MITD) Enters Acquisition Expansion and Growth Phase
Marketwire - Wed Jul 16, 12:30PM CDT
MIT Holding, Inc. (OTCQB: MITD) completes its turn-around phase of operations. The re-organization began in fiscal year 2011, whereas all subsidiaries are now operating with objectives of a 32% net profit.
Pole Position in the US Health Care Upheaval
GlobeNewswire - Mon Mar 31, 10:43AM CDT
The U.S. health care system is on the cusp of a tidal wave of change driven largely by the demands of aging baby boomers and the Obama administration's Affordable Health Care Act. Costs are expected to skyrocket without some major changes, and stakeholders of all stripes -- from doctors to hospitals to insurers -- will be under increasing pressure to deliver their services much more efficiently and cost effectively.
MIT Holding, Inc. (MITD) Wins an Ongoing Clinical Trial Contract From SERRG Savannah, Inc.
Marketwire - Thu Mar 27, 8:03AM CDT
MIT Holding, Inc. (OTCQB: MITD) announces that it was awarded a contract to coordinate, conduct and administer FDA clinical trials for SERRG Savannah Inc. a Multi-Specialty Research Organization. The contract engages MITD immediately and is an open and ongoing agreement for additional trails.
Coastal Carolina Medical Center, Inc. Engages MIT Holding, Inc.'s (MITD) Compounding Pharmacy and Medical Infusion Technologies Divisions
Marketwire - Mon Mar 17, 7:42AM CDT
MIT Holding, Inc. (OTCQB: MITD) announces that Coastal Carolina Medical Center has engaged the "Compounding Pharmacy and Infusion Divisions" of MIT Holding Inc., for initial in hospital treatments of patients. These services will then expand in scope and medications. The administration of infusions will become outpatient in a MIT Holding Infusion facility. The average treatment per patient is expected to bill at an average of $923 per treatment.
MIT Holding, Inc. (MITD) Earnings Projections and Dial in Conference Call on Tuesday, March 18th at 11:30 am ET
Marketwire - Thu Mar 13, 6:40AM CDT
MIT Holding, Inc. (OTCQB: MITD) announces its projected revenues in the first quarter rose 15 percent year over year. The Savannah, GA based holding company estimates 2014 year end revenues of $10 to $15 million with a 30% pretax profit on current and acquired operations.
MIT Holding wins "Renewed Annual Referral Central Network for Patient Transitions" contract
M2 - Tue Mar 11, 6:34AM CDT
MIT Holding (OTCQB:MITD) reported on Monday the receipt of a "Renewed Annual Referral Central Network for Patient Transitions" agreement.
AMGP Georgia Managed Care Company, Inc. Expands Existing MIT Holding, Inc. (MITD) Contract
Marketwire - Tue Mar 11, 6:31AM CDT
MIT Holding, Inc. (OTCQB: MITD) announces that AMGP GEORGIA MANAGED CARE COMPANY, INC., D.B.A. Amerigroup Community Care, revised a "Participating Provider Agreement" to include ambulatory, infusion and perinatal services to the existing "Durable Medical Equipment Contract" (DME). Therefore, the contract will now pay for all services offered by MITD, for a demographically larger range of patients.
Curaspan Health Group Awards Contract to MIT Holding, Inc. (MITD), Accessing the Central Network for Patient Transitions
Marketwire - Mon Mar 10, 7:31AM CDT
MIT Holding, Inc. (OTCQB: MITD) announced today that Curaspan Health Group awarded a "Renewed Annual Referral Central Network for Patient Transitions" contract. This will allow MIT and its future acquisitions to market on a real-time basis the compound pharmaceuticals, infusion services and durable medical equipment directly to the patients of over 5,400 Curaspan medical facilities.
MIT Holding, Inc. (MITD) Announces Negotiations With Leading Private Duty Care and Services Company
Marketwire - Fri Aug 16, 11:25AM CDT
MIT HOLDING, INC. (OTCQB: MITD) announces that it has begun negotiations with a leading South Eastern US private duty care services company. Assisting the in home needs of the elderly and other home bound medical patients, management believes the transaction will close in the next 60 days.
Dow Jones Hits New Highs: Could this Be the Classic Bear Trap? Small Cap Stock Focus List: AMR Corp, Green Innovations, Swingplane Ventures, Red Giant Entertainment, MIT Holding
PR Newswire - Wed Mar 06, 12:24PM CST
The Dow Jones Industrial average traded to new highs once again in trading on Wall Street this Wednesday. The volume is substantial also so this could continue to trade higher throughout the week. Many analysts are saying this is a consumer confidence lead rally and could be leading into at least a 10% market correction.
Stocks Review & Reports: (NASDAQ; ZNGA), (OTCQB: MITD)
ACCESSWIRE-TNW - Wed Mar 06, 11:51AM CST
New York (March 6th, 2013) - Zynga Inc. (NASDAQ: ZNGA) shows neutral trend as the stock made mild down movement in its latest trading session. It opened the session at $3.60 and remained in $3.49 and $3.64 price range during the session. The stock is 0.28 percent lower at $3.53. Zynga's first support level is at $3.25. Upon breaching this level, the stock may go as low as $3.06. On the upside, its first resistance level is at $3.95. Zynga has traded 11.585 million shares so far.
MIT Holding, Inc. (MITD) Enters Acquisition Expansion and Growth Phase
Marketwire - Wed Jul 16, 12:30PM CDT
MIT Holding, Inc. (OTCQB: MITD) completes its turn-around phase of operations. The re-organization began in fiscal year 2011, whereas all subsidiaries are now operating with objectives of a 32% net profit.
Pole Position in the US Health Care Upheaval
GlobeNewswire - Mon Mar 31, 10:43AM CDT
The U.S. health care system is on the cusp of a tidal wave of change driven largely by the demands of aging baby boomers and the Obama administration's Affordable Health Care Act. Costs are expected to skyrocket without some major changes, and stakeholders of all stripes -- from doctors to hospitals to insurers -- will be under increasing pressure to deliver their services much more efficiently and cost effectively.
MIT Holding, Inc. (MITD) Wins an Ongoing Clinical Trial Contract From SERRG Savannah, Inc.
Marketwire - Thu Mar 27, 8:03AM CDT
MIT Holding, Inc. (OTCQB: MITD) announces that it was awarded a contract to coordinate, conduct and administer FDA clinical trials for SERRG Savannah Inc. a Multi-Specialty Research Organization. The contract engages MITD immediately and is an open and ongoing agreement for additional trails.
Coastal Carolina Medical Center, Inc. Engages MIT Holding, Inc.'s (MITD) Compounding Pharmacy and Medical Infusion Technologies Divisions
Marketwire - Mon Mar 17, 7:42AM CDT
MIT Holding, Inc. (OTCQB: MITD) announces that Coastal Carolina Medical Center has engaged the "Compounding Pharmacy and Infusion Divisions" of MIT Holding Inc., for initial in hospital treatments of patients. These services will then expand in scope and medications. The administration of infusions will become outpatient in a MIT Holding Infusion facility. The average treatment per patient is expected to bill at an average of $923 per treatment.
MIT Holding, Inc. (MITD) Earnings Projections and Dial in Conference Call on Tuesday, March 18th at 11:30 am ET
Marketwire - Thu Mar 13, 6:40AM CDT
MIT Holding, Inc. (OTCQB: MITD) announces its projected revenues in the first quarter rose 15 percent year over year. The Savannah, GA based holding company estimates 2014 year end revenues of $10 to $15 million with a 30% pretax profit on current and acquired operations.
MIT Holding wins "Renewed Annual Referral Central Network for Patient Transitions" contract
M2 - Tue Mar 11, 6:34AM CDT
MIT Holding (OTCQB:MITD) reported on Monday the receipt of a "Renewed Annual Referral Central Network for Patient Transitions" agreement.
AMGP Georgia Managed Care Company, Inc. Expands Existing MIT Holding, Inc. (MITD) Contract
Marketwire - Tue Mar 11, 6:31AM CDT
MIT Holding, Inc. (OTCQB: MITD) announces that AMGP GEORGIA MANAGED CARE COMPANY, INC., D.B.A. Amerigroup Community Care, revised a "Participating Provider Agreement" to include ambulatory, infusion and perinatal services to the existing "Durable Medical Equipment Contract" (DME). Therefore, the contract will now pay for all services offered by MITD, for a demographically larger range of patients.
Curaspan Health Group Awards Contract to MIT Holding, Inc. (MITD), Accessing the Central Network for Patient Transitions
Marketwire - Mon Mar 10, 7:31AM CDT
MIT Holding, Inc. (OTCQB: MITD) announced today that Curaspan Health Group awarded a "Renewed Annual Referral Central Network for Patient Transitions" contract. This will allow MIT and its future acquisitions to market on a real-time basis the compound pharmaceuticals, infusion services and durable medical equipment directly to the patients of over 5,400 Curaspan medical facilities.
MIT Holding, Inc. (MITD) Announces Negotiations With Leading Private Duty Care and Services Company
Marketwire - Fri Aug 16, 11:25AM CDT
MIT HOLDING, INC. (OTCQB: MITD) announces that it has begun negotiations with a leading South Eastern US private duty care services company. Assisting the in home needs of the elderly and other home bound medical patients, management believes the transaction will close in the next 60 days.
Dow Jones Hits New Highs: Could this Be the Classic Bear Trap? Small Cap Stock Focus List: AMR Corp, Green Innovations, Swingplane Ventures, Red Giant Entertainment, MIT Holding
PR Newswire - Wed Mar 06, 12:24PM CST
The Dow Jones Industrial average traded to new highs once again in trading on Wall Street this Wednesday. The volume is substantial also so this could continue to trade higher throughout the week. Many analysts are saying this is a consumer confidence lead rally and could be leading into at least a 10% market correction.
Stocks Review & Reports: (NASDAQ; ZNGA), (OTCQB: MITD)
ACCESSWIRE-TNW - Wed Mar 06, 11:51AM CST
New York (March 6th, 2013) - Zynga Inc. (NASDAQ: ZNGA) shows neutral trend as the stock made mild down movement in its latest trading session. It opened the session at $3.60 and remained in $3.49 and $3.64 price range during the session. The stock is 0.28 percent lower at $3.53. Zynga's first support level is at $3.25. Upon breaching this level, the stock may go as low as $3.06. On the upside, its first resistance level is at $3.95. Zynga has traded 11.585 million shares so far.
